1 |
식품의약품안전청 (2010). 생물학적동등성시험기준(고시 제2010-43호).
|
2 |
Chow, S. C. and Liu, J. P. (2008). Design and Analysis of Bioavailability and Bioequivalence Studies, 3rd edition, Chapman & Hall/CRC.
|
3 |
Ko, S. and Oh, H. (1999). Assessment and Interpretation for Two Drug Formulations using Crossover Design, The Korean Communications in Statistics, 6, 601–609.
과학기술학회마을
|
4 |
Patel, H. I. (1983). Use of baseline measurements in the two-period crossover design, Communications in Statistics, Theory & Methods, 12, 2693–2712.
|
5 |
Schuirmann, D. J. (1987). A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability, Journal of Pharmacokinetics and Pharmacodynamics, 15, 657–680.
|